Xcout Intel
Ultragenyx
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.
Subscribe to see Ultragenyx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ultragenyx at a glance
Ultragenyx is a biotech company headquartered in Japan. Xcout tracks 16 named people at Ultragenyx, including Howard Horn (Chief Financial Officer and Executive Vice President, Corporate Strategy). Xcout recorded 67 job postings from Ultragenyx in the last 90 days, naming tools such as SAP, Cisco, Meraki.
Ultragenyx leadership
- Howard HornChief Financial Officer and Executive Vice President, Corporate Strategy
- Dennis HuangChief Technical Operations Officer and Executive Vice President, Gene Therapy Research and Development
- Eric Crombez, M.D.Chief Medical Officer and Executive Vice President
- Eric OlsonChief Business Officer and Executive Vice President
- Erik HarrisChief Commercial Officer and Executive Vice President
- Ernie MeyerChief Human Resources Officer and Executive Vice President
10 more named people on record for Ultragenyx, with roles, board committees and tenure — see the full roster →
Hiring at Ultragenyx
Xcout recorded 67 job postings from Ultragenyx in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Ultragenyx's job postings
The weekly hiring trend, the roles and locations behind it — see Ultragenyx's hiring signals →
Hiring vs the trend
Based on 39 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 158 scale-up healthcare companies.
This describes a hiring pattern — how often Ultragenyx’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Ultragenyx competitors
A few of Ultragenyx's closest competitors — see the full list of competitors and alternatives →
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
Applied Therapeutics, Inc. is a biopharmaceutical company headquartered in New York City, focused on developing novel product candidates targeted at disease targets involving enzyme and metabolic pathways.
Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders.
Orchard Therapeutics plc is a biopharmaceutical company with operations including a U.S. headquarters located in Boston, Massachusetts.
Amicus Therapeutics, Inc. is an American biopharmaceutical company focused on discovering and delivering advanced therapies for rare diseases. The company is publicly traded on Nasdaq and maintains its global corporate headquarters in Princeton, New Jersey.
Get Ultragenyx's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ultragenyx in Xcout Intel
- 16 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access